NCT07179939 2025-09-18Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II StudyFudan UniversityPhase 2 Not yet recruiting288 enrolled
NCT07101159 2025-08-03Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage PatientsFujian Cancer HospitalPhase 2 Not yet recruiting200 enrolled